Health Care: Drugs

Sunesis Pharmaceuticals Inc (SNSS: NASDAQ)

$2.65 -0.29 | -9.86%
06/28/17 - 01:49 PM ET
Company Profile
Price and Volume
Recent Price 2.94
52 Week High 6.30
52 Week Low 2.73
Avg. Daily Vol. (Mil) 0.14
Beta (3 year) 0.57
Share Related Items
Mkt Cap (Mil) 63.09
Shares Out (Mil) 21.46
Float (Mil) 19.55
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.10
Current Ratio 3.10
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 24.60
Price/Book 0.00
Price/Cash Flow -1.70
Per Share Data
Earnings -2.19
Sales 0.12
Book Value 0.00
Cash Flow -1.74
Business Summary
Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.
General Information
395 Oyster Point Boulevard
Suite 400
South San Francisco, CA 94080
Industry : Drugs
Sector: Health Care
Employees: 37
CEO: Daniel N. Swisher,Jr
Short Interest
Current Month (Mil) 0.26
Previous Month (Mil) 0.27
Short Interest Ratio (Days) 4.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -105.20
Return on Investments -155.80
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with SNSS

Latest SNSS Headlines from TheStreet

More Financial News for SNSS

Press Releases for SNSS

See All Press Releases

Partner Headlines for SNSS

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter